Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620514 · ClinicalTrials.gov registry record · NA
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02620514: Completed NA study, sponsored by Emory University.
NCT02620514 is a NA study that has completed, run by Emory University. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02620514, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this is to formally assess health literacy and medication adherence in participants with Inflammatory bowel disease (IBD). The study also aims to improve medication adherence, health-related quality of life, and disease activity through a 24-week intervention.
Primary Outcome
The Medication possession Rate (MPR) will be calculated as the amount of medication consumed divided by days in the interval and adherence will be defined as greater than 80%.
Interventions
- BEHAVIORAL Financial Support
- BEHAVIORAL Education and Reminders
- BEHAVIORAL Educational Visit
- BEHAVIORAL Medication Educational Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-11-01 |
| Phase | NA |
What the finished NCT02620514 record still lists
NCT02620514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Financial Support is the first listed.
NCT02620514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02620514 about?
NCT02620514 is a clinical study titled "Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)". The purpose of this is to formally assess health literacy and medication adherence in participants with Inflammatory bowel disease (IBD). The study also aims to improve medication adherence, health-related quality of life, and disease activity through a 24-week intervention.
What is the current status of trial NCT02620514?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2015-06. Estimated completion is 2016-11-01.
What interventions are being tested in trial NCT02620514?
The interventions under investigation include: Financial Support (BEHAVIORAL), Education and Reminders (BEHAVIORAL), Educational Visit (BEHAVIORAL), Medication Educational Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT02620514?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02620514's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia